QZQiyan Zeng

Qiyan Zeng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qiyan Zeng has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Faquan Lin

    Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China

    5 shared publications
  • Linjie Zeng

    Department of Orthopaedics, Chinese and Western, Orthopaedics Hospital of Guigang, Guigang, Guangxi, 537100, People's Republic of China

    4 shared publications
  • Yangyang Zhang

    Department of Biochemistry and Molecular Biology Guangxi Medical University Nanning Guangxi People's Republic of China

    4 shared publications
  • Yi Liu

    Department of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning, People’s Republic of China

    4 shared publications
  • Yu Huang

    4 shared publications
  • Binbin Xie

    Department of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning, People’s Republic of China

    3 shared publications

Latest Publications

  • Open Access

    SENP1: A perspective from immune cells to disease (Review)

    by Xiaofang Feng, Guoyu Wu, Qiyan Zeng

    Small ubiquitin‑like modifier (SUMO) is a ubiquitin‑like protein that modifies target proteins across various eukaryotic subcellular structures. This process, known as SUMOylation, has been established as an essential regulatory mechanism that affects both the activity and positioning of proteins, maintaining cellular homeostasis. SUMOylation and deSUMOylation are reversible post‑translational modification processes mediated by SUMO proteins and SUMO/sentrin‑specific proteases (SENPs). The human SENP family comprises six members, each characterized by unique cellular localization and substrate specificity. The present review primarily summarizes the role and mechanisms of SENP1 in the development and maturation of immune cells, including lymphocytes, macrophages and erythrocytes, as well as its involvement in tumor cell invasion, metastasis, angiogenesis and resistance to pharmacological therapies. In addition, the introduction of SENP1 inhibitors as a therapeutic approach for cancer treatment is explored. Overall, the present study aimed to offer theoretical insights into cancer therapy strategies that target SENP1.


  • Open Access

    The diagnostic value of a breast cancer diagnosis model based on serum MiRNAs and serum tumor markers

    by Xiaohui Li, Feng Wang, Faquan Lin, Binbin Xie, Yi Liu, Yi Xiao, Kai Qin, Weicheng Li, Qiyan Zeng

    Background: Breast cancer (BCa) is the leading cause of cancer-related death among women worldwide. MicroRNAs (miRNAs) are promising tools for diagnosis and prognosis. This study investigated the role of serum miRNAs and tumor markers (TMs) in the diagnosis of BCa. Methods: Differentially expressed miRNAs were screened from serum samples of BCa patients and healthy individuals via high-throughput sequencing. The expression of hsa-miR-1911-3p, hsa-miR-4694-5p, hsa-miR-548ao-5p, and hsa-miR-4804-3p in 169 BCa patients and 116 healthy controls was detected via qRT-PCR. Serum tumor-associated antigens were detected by chemiluminescence. Logistic regression was subsequently used to develop the miRNA panel I, TM panel II, and (miRNA + TM) panel III models. Receiver operating characteristic (ROC) curve, precision-recall (PR) curve and decision curve analyses (DCA) were performed to assess the accuracy of the three models for BCa diagnosis. Additionally, the relationships between miRNA expression and the clinical characteristics of patients with BCa were assessed. Results: Four serum miRNAs (hsa-miR-1911-3p, hsa-miR-548ao-5p, hsa-miR-4694-5p, and hsa-miR-4804-3p) were newly associated with BCa. The miRNA panel I based on hsa-miR-548ao-5p and hsa-miR-4804-3p showed greater diagnostic effectiveness for BCa than TM panel II based on cancer antigen 125 (CA125) and cancer antigen 153 (CA153), with AUC values of 0.816 and 0.777, respectively. (miRNA + TM) panel III had higher diagnostic effectiveness than miRNA panel I, with an AUC value of 0.870. The expression of miR-548ao-5p and miR-4804-3p is closely related to clinical features, such as human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), progesterone receptor (PR), HER2-enriched subtype, stage III/IV, and lymph node-transplanted breast cancer. Conclusion: MiR-548ao-5p and miR-4804-3 could serve as potential biomarkers for the diagnosis of BCa.


  • Open Access

    Long noncoding RNA00324 is involved in the inflammation of rheumatoid arthritis by targeting miR‐10a‐5p via the NF‐κB pathway

    by Binbin Xie, Faquan Lin, Wei Bao, Yangyang Zhang, Yi Liu, Xiaohui Li, Wei Hou, Qiyan Zeng

    Background: Altered expressions of genes in immune cells and synovial tissues are involved in the pathology of rheumatoid arthritis (RA). Long noncoding RNAs act as competing endogenous RNAs and can cause immune disorders. The goal of this study was to reveal the association between noncoding RNA linc00324 and RA, and a plausible action mechanism was proposed.Methods: RT‐qPCR was used to evaluate the expression of linc00324 in peripheral blood mononuclear cells isolated from 50 RA patients and 50 healthy controls, and the correlations between linc00324 level and the clinical indicators were analyzed. Flow cytometry was used to characterize CD4+ T cells. The effects of linc00324 on cytokine production and cell proliferation of CD4+ T cells were evaluated by ELISA assay and Western blot. The interaction between linc00324 and miR‐10a‐5p was investigated by RNA immunoprecipitation and dual‐luciferase assays.Results: The linc00324 expression was significantly enhanced in RA patients, and linc00324 expression was positively correlated with rheumatoid factor and CD4+ T cells. Overexpression of linc00324 promoted CD4+ T cells proliferation, and enhanced chemokine MIP‐1α secretion and NF‐κB phosphorylation level, whereas knockout of linc00324 blocked CD4+ T cell proliferation and NF‐κB phosphorylation. Overexpression of miR‐10a‐5p led to the decrease of CD4+ T cells proliferation and NF‐κB phosphorylation, and reversed the effects of linc00324 on cell proliferation and NF‐κB activity.Conclusion: Linc00324 was upregulated in RA and may exaggerate inflammation by targeting miR‐10a‐5p through NF‐κB signaling pathway.


  • Open Access

    Correction for: Long intergenic non-protein coding RNA 324 prevents breast cancer progression by modulating miR-10b-5p

    by Bo Wang, Yangyang Zhang, Haitian Zhang, Faquan Lin, Qixin Tan, Qinghong Qin, Wei Bao, Yi Liu, Jiaying Xie, Qiyan Zeng

  • Open Access

    Long intergenic non-protein coding RNA 324 prevents breast cancer progression by modulating miR-10b-5p

    by Bo Wang, Yangyang Zhang, Haitian Zhang, Faquan Lin, Qixin Tan, Qinghong Qin, Wei Bao, Yi Liu, Jiaying Xie, Qiyan Zeng

    Mounting evidence suggests that long noncoding RNAs serve as specific biomarkers and potent modulators of multiple cancers. Long intergenic non-protein coding RNA 324 (LINC00324) is ubiquitously expressed in various tissues, including breast cancer. The biological function of LINC00324 in the development and progression of breast cancer remains unknown. Here, we fully elucidate the relation between LINC00324 expression and breast cancer, and suggest a potential mechanism of action. We found that decreased expression of LINC00324 was dramatically correlated with malignancy of breast cancer, both in breast cancer tissues and in cell lines. Overexpression of LINC00324 in MDA-MB-231 cells resulted in a decrease in cell proliferation, invasion, and migration, while increasing cells apoptosis. On the other hand, loss-of-function experiments indicated that deficiency of LINC00324 promoted malignant phenotypes in breast cancer cells. Mechanically, we found that LINC00324 is mainly distributed in the cytoplasm, fostering the expression of E-cadherin by sponging miR-10b-5p. Taken together, these findings suggest that LINC00324 plays a critical role in breast cancer progression by directly interacting with miR-10b-5p. LINC00324 can thus potentially act as an early diagnostic marker and a novel therapeutic agent for breast cancer.


    • 1 September 2019
      • Vol. 35  (9) , 832-837

    [Correlation analysis between LINC00324 and immunophenotype in peripheral blood leukocytes in patients with acute myeloid leukemia].

    by Yi Liu, Yangyang Zhang, Jiaying Xie, Wei Bao, Binbin Xie, Jicheng Zhou, Qiyan Zeng

    Objective To investigate the relationship between long-chain intergenic non-coding RNA324 (LINC00324) and immunophenotype in peripheral blood leukocytes of acute myeloid leukemia (AML) patients. Methods Real-time quantitative PCR and bioinformatics databases were utilized to analyze the expression level of LINC00324 in peripheral blood leukocytes and cell lines KG-1, THP-1 and U937 in AML patients. The relationships of the expression level of LINC00324 with the red blood cell and platelet count, the expression levels of LINC00324 and immunophenotypes in 40 AML patients were analyzed by Person correlation analysis. The immunophenotypes included CD14, CD68, CD64, CD11b, CD4, CD45, CD33, HLA-DR, CD163, CD2, CD58, CD117, CD43, CD34, CD99, CD8, CD38, CD10, CD13, CD56, CD7, TdT, CD235a, CD138, CD61, MPO and CD19. Simultaneously, the cBioPortal database datasets (TCGA, NEJM 2013) were used to analyze the clinical characteristics of 173 AML patients, and to analyze the correlations between the expression level of LINC00324 and the peripheral blood blast percentage and white blood cell count in tumor samples. Results The expression of LINC00324 in peripheral blood leukocytes of AML patients was down-regulated, and its expression level was significantly correlated with immunophenotype CD33, red blood cell and platelet count. Analysis of bioinformatics database showed that LINC00324 was under-expressed in myeloid leukemia cell lines. The expression of LINC00324 in AML patients was associated with multiple immunophenotypes such as CD33, CD117, CD11b, CD14 and CD64 and was negatively correlated with peripheral blood blast percentage and white blood cell count. Conclusion LINC00324 may be involved in regulating the differentiation, development and function of immune cells, which providing a new strategy for the development of targeted drugs or treatment of AML.

  • Mitogenic activity of Artocarpus lingnanensis lectin and its apoptosis induction in Jurkat T cells

    by Linjie Zeng, Lu Li, Qiyan Zeng, Yong Deng, Lijun Yin, Liejun Liao

    Lectins are a class of carbohydrate-binding proteins or glycoproteins and used in the purification and characterization of glycoproteins according to their specificity to carbohydrates. In the present study, the mitogenic activity of Artocarpus lingnanensis lectin (ALL) and its apoptosis induction in Jurkat T cells were explored. MTT assay revealed strong mitogenic potential of ALL. Meanwhile, the anti-cancer activity of ALL was also explored using the human leukemic Jurkat T cell line. ALL exhibited strong binding affinity (97%) to the cell membrane, which could be effectively inhibited by N-acetyl-d-galactosaminide (NAD). ALL induced time- and dose-dependent growth inhibition in Jurkat T cells. ALL could induce morphologic change and increase the hypodiploid cell population with the decreased population of S and G2/M phases. The induction of phosphatidylserine externalization and PARP cleavage further confirmed its apoptosis-inducing activity due to the activation of caspase-8 and -9. The inhibition of caspase-9 but not caspase-8 could rescue ALL-induced apoptotic cells. Further studies showed that ALL enhanced the cleavage of Bid, the release of cytochrome C, the depolarization of mitochondria and the activation of caspase-3. ALL downregulated the expression of Bcl-xl and Bcl-2 without impact on Bax and Bad. In addition, the activation of p38/JNK MAPK signaling pathways was observed to be a requisite for ALL apoptotic activity. In contrast, ALL could not induce apoptosis of normal T cells. These findings present the differential effect of ALL on Jurkat and normal T lymphocytes, suggesting its therapeutic value in leukemia.


  • Cloning of a novel lectin from Artocarpus lingnanensis that induces apoptosis in human B-lymphoma cells

    by Yu Luo, Xiaoqin Liu, Faquan Lin, Liejun Liao, Yong Deng, Linjie Zeng, Qiyan Zeng

    We isolated a novel lectin (Artocarpus nitidus subsp. lingnanensis lectin, ALL) from Artocarpus nitidus subsp. lingnanensis and showed its mitogenic activities. In this study, we determined the amino acid sequence of ALL by cDNA sequencing. ALL cDNA (933 bp) contains a 657-bp open reading frame (ORF), which encodes a protein with 218 amino acids. ALL shares high sequence similarities with Jacalin and Morniga G and belongs to jacalin-related lectin family. We also examined the antitumor activity of ALL using Raji, a human B-lymphoma cell line. ALL exhibits a strong binding affinity to cell membrane, which can be effectively inhibited by N-acetyl-D-galactosamine (GalNAc). ALL inhibits Raji cell proliferation in a time- and dose-dependent manner through apoptosis, evidenced by morphological changes, phosphatidylserine externalization, poly ADP-ribose polymerase (PARP) cleavage, Bcl-2 down-regulation, and caspase-3 activation. We further showed that the activation of p38 mitogen-activated protein kinase (MAPK) signaling pathways is required for the pro-apoptotic activity of ALL. ALL is a novel member of Jacalin-related lectins. ALL stimulates p38 MAPK signaling pathway and inhibits Raji cell proliferation through apoptosis.